Pfizer
NIVESTYM
Manufacturer:
Pfizer
Name:
NIVESTYM
HCPCS Code Descriptor:
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
Category:
Q Code
HCPCS:
Q5110
NDC(s):
00069-0291-01, 00069-0291-10, 00069-0292-01, 00069-0292-10, 00069-0293-10, 00069-0294-10
Primary Type:
Oncology Biosimilar Colony Stimulating Factor
Generic Status:
Single-Source
Route of Administration:
Injection
About:
NIVESTYM is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Pfizer and administered via the Injection route of administration. The Q Code: Q5110 is aligned to the drug NIVESTYM.
Nivestym (pegfilgrastim) is an artificial protein that aids the production of white blood cells (neutrophils). Nivestym is manufactured by Pfizer and is biosimilar to the drug Neupogen (J1442). This drug has one HCPCS code, Q5110 that has been aligned to the medication since October 2018. Patient assistance programs for this medication can be found through Pfizer RxPathways.